PI3Kγ Activates Integrin α₄ and Promotes Immune Suppressive Myeloid Cell Polarization during Tumor Progression.

Area of Science:

• Immunology
• Cancer Biology
• Molecular Medicine

Background:

• Myeloid-derived suppressor cells (MDSCs) and tumor-associated macrophages (TAMs) accumulate in tumors, suppressing T cell immunity and promoting tumor progression.
• Myeloid cell phosphoinositide 3-kinase gamma (PI3Kγ) regulates tumor immune suppression by influencing MDSC recruitment and polarization.
• Integrin α4 is implicated in MDSC recruitment and polarization downstream of PI3Kγ.

Purpose of the Study:

• To investigate the role of PI3Kγ and integrin α4 in myeloid cell-mediated tumor immune suppression.
• To determine if targeting PI3Kγ or integrin α4 can restore antitumor immunity.

Main Methods:

• Genetic or pharmacological suppression of PI3Kγ or integrin α4 in a tumor model.
• Analysis of myeloid cell infiltration, polarization, cytokine expression (IL-10, IL-12, IFNγ), and immune cell recruitment (dendritic cells, CD8+ T cells).
• Assessment of tumor cell cytotoxicity and tumor growth inhibition *in vivo*.

Main Results:

• Suppression of PI3Kγ or integrin α4 blocked MDSC recruitment and immunosuppressive polarization of MDSCs and TAMs.
• Targeting PI3Kγ or integrin α4 reduced IL-10 and increased IL-12 and IFNγ expression within tumors.
• Inhibition of PI3Kγ or integrin α4 stimulated dendritic cell and CD8+ T cell responses, increased tumor cell cytotoxicity, and inhibited tumor growth.

Conclusions:

• Integrin α4 acts downstream of PI3Kγ to promote immunosuppressive myeloid cell polarization, inhibiting antitumor immunity.
• PI3Kγ and integrin α4 are critical regulators of the tumor immune microenvironment and represent promising therapeutic targets for cancer immunotherapy.